Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

SELL
$44.49 - $62.93 $44 - $62
-1 Reduced 25.0%
3 $0
Q3 2023

Oct 12, 2023

BUY
$45.51 - $65.0 $136 - $195
3 Added 300.0%
4 $0
Q4 2022

Jan 13, 2023

BUY
$27.93 - $31.27 $27 - $31
1 New
1 $0
Q2 2022

Jul 07, 2022

SELL
$29.79 - $42.29 $89,370 - $126,870
-3,000 Closed
0 $0
Q2 2021

Jul 06, 2021

BUY
$17.11 - $20.92 $51,330 - $62,760
3,000 New
3,000 $60,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.64B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.